Hemangioendothelioma — Trials

Hemangioendothelioma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06239272	NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)	recruiting	Phase 1 / Phase 2	139	St. Jude Children's Research HospitalOTHER	1	Aug 3, 2026	clinicaltrials
NCT05228015	Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors	terminated	Phase 1	67	Ikena OncologyINDUSTRY	3	Nov 18, 2024	clinicaltrials
NCT06452160	A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors	recruiting	Phase 1	103	BridGene Biosciences Inc.INDUSTRY	1	Aug 9, 2024	clinicaltrials
NCT01154452	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Data updated 22 days agoSource updated Aug 3, 2026source: clinicaltrials